Latest Drug Approvals news
FDA Approves Belimumab Autoinjector for Pediatric Systemic Lupus Erythematosus
posted May 22nd
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves New Antibiotic for Uncomplicated Urinary Tract Infections
posted April 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Anktiva for BCG-Unresponsive, Non-Muscle Invasive Bladder Cancer
posted April 26th
by modernClinician Editorial Team
by modernClinician Editorial Team
Alecensa Approved as First and Only ALK Inhibitor for Non-Small Cell Lung Cancer
posted April 22nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Thymic Radiation Linked to Worse Outcomes in Patients With NSCLC 
Lung Transplant Can Prolong Survival in Stage IV NSCLC 
Risk-Based Strategies Superior to USPSTF Criteria for Lung Cancer Screening 
Mesothelioma Diagnoses and Deaths Still Increasing Related Articles
Most Speakers at FDA Advisory Committee Meetings Support Drug Approval 
Countries Involved in U.S. Clinical Trials Do Not Gain Timely Access to Approved Medicines 
FDA Picks George Tidmarsh to Head Center for Drug Evaluation and Research 
Approved-Label Populations for New Drugs Broader Than Trial Populations Monthly Specialist Briefings
Stay Connected
